KRAS and cancer: Kirsten rat sarcoma viral oncogene homologue (KRAS)—one of the most prevalent cancer driver genes—is mutated in approximately 95% of pancreatic cancer [1], 50% of colorectal cancer [2], and 20% of non-small-cell lung cancer (NSCLC) [3] cases.